Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines.
A number of DNA fragments, identified by representational difference analysis, which were homozygously deleted in various cancer cell lines were previously mapped to human chromosomal arms. One of these, BE758-6, which was homozygously deleted in a number of colon carcinoma cell lines, had been mapped to chromosome region 3p. We have further localized the probe to 3p14.2, approximately 350kbp telomeric to the 3p14.2 break of the t(3;8) hereditary renal cell carcinoma chromosome translocation, within or near the 3p14.2 FRA3B, the most common human fragile site. We determined the sizes of the homozygous deletions in a number of cancer cell lines after isolation of a yeast artificial chromosome contig and development of STS markers which fall between D3S1234 and D2S1481, which flank the deletions. Homozygous deletions were observed and sized not only in the cell lines originally reported but also in a number of nasopharyngeal carcinoma cell lines and a gastric carcinoma cell line. About 50% of uncultured stomach and colon carcinomas were then shown to lose heterozygosity for alleles in the same region, with a common region of loss between the D3S1234 and D3S1481 markers. Thus, it is likely that the homozygous deletion observed in these cancer cell lines harbors an important tumor suppressor gene for several tumor types.
Kastury
K
K
Jefferson Cancer Institute, Jefferson Medical College, Philadelphia, Pennsylvania 19107-6799, USA.
Baffa
R
R
Druck
T
T
Ohta
M
M
Cotticelli
M G
MG
Inoue
H
H
Negrini
M
M
Rugge
M
M
Huang
D
D
Croce
C M
CM
Palazzo
J
J
Huebner
K
K
D001483:Base Sequence; D014408:Biomarkers, Tumor / Q000235:genetics; D002874:Chromosome Mapping; D002893:Chromosomes, Human, Pair 3; D005770:Gastrointestinal Neoplasms / Q000235:genetics*; D017353:Gene Deletion; D016153:Genes, Suppressor; D006720:Homozygote; D006801:Humans; D008969:Molecular Sequence Data; D014407:Tumor Cells, Cultured
D014408:Biomarkers, Tumor